Agence de Médecine Préventive (AMP) Afrique

Africa CDC is moving towards declaring a continent-wide public health emergency. Join us for a special press briefing to learn more about this crucial step and its implications for Africa's health security. 📅 Date: 13 August 2024  ⏰ Time: 4:00pm - 5:00pm | East Africa Time (GMT+3) 📍 Link to join the briefing: https://lnkd.in/dDH7pRhx #PublicHealth #HealthSecurity 

In the last weeks, our efforts have been dedicated to discussions/workshops around strengthening Ebola Virus Disease (EVD) preparedness, outbreak response and prevention in high-risk countries, and aligning national strategies with the new SAGE recommendations on EVD preventive vaccination. AMP Afrique has been organizing knowledge-sharing and momentum building workshops among high-risk African countries stratified into two cohorts Anglophone and Francophone. The Anglophone met in Freetown (Sierra Leone) and Francophone met in Congo-Brazzaville. The targets key stakeholders included countries public health authorities, EPI managers, NITAGs, Emergency response centers,  and representatives of international organizations e.g., WHO HQ and Afro, UNIVEF, Africa CDC, CEPI, etc. The main workshop outcomes included: - Understanding the current state of EVD in the region and developing national strategies or plans for transitioning from EVD outbreak response to prevention through vaccination as prophylaxis. - Building resilient health systems for long-term EVD preparedness and prevention through strengthening priority strategies such as health policy & demand generation, surveillance, operations and logistics, service delivery and implementation research. - Providing a platform for countries to share their experiences and challenges, identifying gaps in preparedness and response, and developing roadmaps to strengthen their capacity to prevent and control future EVD outbreaks using vaccine as prophylaxis. - A resolve amongst countries stakeholders and partners to use the developed roadmap or action plans as updated national strategy for EVD vaccine introduction tagged “from EVD response to prevention”. - Connecting countries to Gavi call for vaccine funding application

At AMP Afrique our journey in the malaria world, spanning from 2011, has been marked by a resolute commitment to increasing awareness on malaria disease and closing critical knowledge gaps in malaria surveillance. During the past years, AMP Afrique has laid a solid foundation for designing clinical trials and implementing capacity building particularly concerning the RTS,S/AS01 vaccine. To date, more than 2500, both medical and non-medical personnel, have benefited from AMP’s malaria training program and undergone rigorous supervision. As the project approaches its culmination AMP Afrique would like to take the opportunity of the commemoration of the world malaria day to thank all our partners for the dedication and commitment #GSK #WHO #KEMRI (Kenya Medical Research Institute- Kenya) #CREATES (Centre for Research in Therapeutic Science- Kenya) #CNRFP (Centre national de recherche et de formation sur le Paludisme- Burkina Faso) #CRSN (Centre de recherche en santé de Nouna - Burkina Faso) #NIAKHAR (Centre de recherche de Niakhar- Senegal) #NHRC (Navrongo Health Research Centre – Ghana) #KHRC (Kintampo Health Research Centre- Ghana) #NIMR (National Institute for Medical Research- Tanzania) #COM (University of Malawi College of Medicine- Malawi) #MLW (Malawi-Liverpool Wellcome Trust- Malawi). With the AMVIRA (Accelerating Malaria Vaccine Introduction and Rollout in Africa) project now in focus, let’s move in the direction of the implementation  with the 2 safe and effective vaccines RTS,S/AS01 and R21/Matrix-M, recommended by WHO to prevent malaria in children. If implemented widely, malaria vaccines could save tens of thousands of lives each year # Vaccineswork

Cette année encore l'AMP Afrique poursuivra son engagement auprès des communautés et des gouvernements de notre région pour l'amélioration de nos indicateurs de santé. Excellente année 2024!

The current Dengue and Zika epidemics affecting over a dozen of African countries highlight a renewed call and critical need for improved coordination in responding to health emergencies. Agence de Medecine Preventive Afrique (AMP Afrique) organized a table-top simulation exercise (TTX) on December 11-13, 2023, in Abidjan, to test the contingency plans of the participating countries, including Mali, Burkina Faso, Côte d'Ivoire, Guinea, DRC. During the exercise, the participants identified gaps in terms of i) emergency coordination; ii) cross-border collaboration, iii) communication and information sharing, and iv) involvement of animal and environmental health.   Some key takeaways from this TTX emphasize the importance of: - The establishment of regional contingency plans - The development of regulatory documents for inter-country coordination - The mapping of trained human resources at country and regional level - The Digitization of data - The urgent integration of climate change and the use of AI in predicting epidemics   We are pleased to have established this new collaborative network between officials from Public Health Emergency Operations Centers (PHEOCs) from the countries involved and regional or international health organizations. We would like to express our gratitude to our technical and financial partners, including #Jhpiego, #CDC Africa, #MSD, #WHO, #CDC Atlanta, #WAHO, #FAO, #CEPI, #CSRS, and the Geneva Centre for Security Policy. Dr Tene-Alima ESSOH

The current Dengue and Zika epidemics affecting over a dozen of African countries highlight a renewed call and critical need for improved coordination in responding to health emergencies. Agence de Medecine Preventive Afrique (AMP Afrique) organized a table-top simulation exercise (TTX) on December 11-13, 2023, in Abidjan, to test the contingency plans of the participating countries, including Mali, Burkina Faso, Côte d'Ivoire, Guinea, DRC. During the exercise, the participants identified gaps in terms of i) emergency coordination; ii) cross-border collaboration, iii) communication and information sharing, and iv) involvement of animal and environmental health.   Some key takeaways from this TTX emphasize the importance of: - The establishment of regional contingency plans - The development of regulatory documents for inter-country coordination - The mapping of trained human resources at country and regional level - The Digitization of data - The urgent integration of climate change and the use of AI in predicting epidemics   We are pleased to have established this new collaborative network between officials from Public Health Emergency Operations Centers (PHEOCs) from the countries involved and regional or international health organizations. We would like to express our gratitude to our technical and financial partners, including #Jhpiego, #CDC Africa, #MSD, #WHO, #CDC Atlanta, #WAHO, #FAO, #CEPI, #CSRS, and the Geneva Centre for Security Policy. Dr Tene-Alima ESSOH

Il est établit que les femmes vivant avec le VIH ont 6 fois plus de risque de développer un cancer du col de l’utérus. Et pourtant, nos programmes de vaccination contre le HPV, le virus à l’origine du cancer du col de l’utérus, n’arrivent pas à toujours correctement adresser la vaccination anti-HPV des jeunes filles vivant avec le VIH : comment s’assurer qu’elles reçoivent le nombre correcte de doses de vaccin anti-HPV ? Comment éviter la stigmatisation alors que cette vaccination anti-HPV est essentiellement offerte à l’école et que le schéma vaccinal différe pour les filles vivant avec le VIH ? comment adresser la question de l'équité en matière de lutte contre le cancer du col de l'utérus? Dans le cadre de son engagement, le laboratoire MSD a organisé au caire en Egypte le « “HIV Scientific Forum: Addressing HIV management in the MENA region”. Cette rencontre, spécifique à la région MENA (Middle East and North Africa) à vu la participation d’experts du Maroc, Algérie, Arabie Saoudite, Oman, etc..L’AMP Afrique à pris part à la session « Integrating HPV prevention into HIV care » afin de souligner l’urgence de la sensibilisation des professionnels de la santé en charge des patientes vivant avec le VIH. Il est important que le dépistage du CCU soit proposé à ces femmes; Il est également important que la vaccination anti-HPV contre le cancer du col de l’utérus soit systématiquement proposée aux jeunes filles vivants avec le VIH lors des visites de suivi médical. Il est enfin primordial de disposer de données factuelles, locales afin de suivre la durée de l’efficacité vaccinale et la durée de protection anti-HPV chez ces jeunes filles au système immunitaire fragilisé (VIH, personnes transplantées, etc..), d'estimer la necessité de leur administrer des doses de rappel, d'évaluer l’impact du traitement ART sur l’efficacité vaccinale, etc…des questions auxquelles le centre de recherche de KEMRI au Kenya tente d’apporter des réponses. En attendant que d’autres centres leur emboite le pas 1 femme meurt toute les 2 minutes du cancer du col de l’utérus et le risque que cette femme soit notre sœur, mère, amie, cousine, tante est grand ! Le cancer du col de l’utérus est évitable par la vaccination. Dr Tene-Alima ESSOH #vaccineswork ; #HPVvaccination; #cervicalcancerelimination